• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用实施科学理论开发和扩展青霉素过敏去标签干预措施的应用。

Leveraging implementation science theories to develop and expand the use of a penicillin allergy de-labeling intervention.

机构信息

Department of Surgery, University of Wisconsin-Madison, 600 Highland Avenue, Madison, 53792-7375, WI, USA.

William S. Middleton Veterans Memorial Hospital Madison, Madison, WI, USA.

出版信息

BMC Health Serv Res. 2024 Aug 26;24(1):987. doi: 10.1186/s12913-024-11364-7.

DOI:10.1186/s12913-024-11364-7
PMID:39187854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11348780/
Abstract

BACKGROUND

Penicillin allergy is the most frequently reported drug allergy, yet most patients can tolerate the drug if challenged. Despite this discrepancy, large scale penicillin allergy de-labeling interventions have not been widely implemented in many health care systems. The application of a multi-method implementation science approach can provide key tools to study this evidence to practice gap and provide insight to successfully operationalize penicillin allergy evaluation in real-world clinical settings.

METHODS

We followed a four-step process that leverages qualitative analysis to design evidence-based, actionable strategies to develop an intervention. First, we specified the clinician-perceived barriers to penicillin allergy de-labeling (intervention targets). We then mapped intervention targets onto Theoretical Domains Framework (domains and constructs) and found the root causes of behavior. Next, we linked root causes of behavior with intervention functions (BCW). In the final step, we synthesized participants' suggestions for process improvement with implementation strategies aligning with the intervention functions.

RESULTS

Evidence-based strategies such as focused education and training in penicillin allergy evaluation can address knowledge and confidence barriers reported by frontline clinicians. Other key strategies involve developing a system of champions, improving communications systems, and restructuring the healthcare team. Implementation mapping can provide a powerful multi-method framework to study, design, and customize intervention strategies.

CONCLUSION

Empowering clinicians beyond allergy specialists to conduct penicillin allergy assessments requires designing new workflows and systems and providing additional knowledge to those clinicians.

摘要

背景

青霉素过敏是最常报告的药物过敏,但大多数患者如果受到挑战,仍能耐受该药物。尽管存在这种差异,但在许多医疗保健系统中,大规模的青霉素过敏去标签干预措施并未广泛实施。应用多方法实施科学方法可以为研究这一证据与实践差距提供关键工具,并深入了解如何在现实临床环境中成功实施青霉素过敏评估。

方法

我们遵循了一个四步流程,利用定性分析来设计基于证据的、可操作的策略来开发干预措施。首先,我们确定了临床医生认为的青霉素过敏去标签障碍(干预目标)。然后,我们将干预目标映射到理论领域框架(领域和结构)上,并找到了行为的根本原因。接下来,我们将行为的根本原因与干预功能(BCW)联系起来。在最后一步,我们综合了参与者对改进流程的建议和与干预功能相一致的实施策略。

结果

基于证据的策略,如针对青霉素过敏评估的集中教育和培训,可以解决一线临床医生报告的知识和信心障碍。其他关键策略包括培养拥护者系统、改善沟通系统和重组医疗团队。实施映射可以为研究、设计和定制干预策略提供一个强大的多方法框架。

结论

要使非过敏专科医生能够进行青霉素过敏评估,需要设计新的工作流程和系统,并向这些临床医生提供额外的知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/1ebdbf7d5552/12913_2024_11364_Figd_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/13242ac7d367/12913_2024_11364_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/ab9e81ba03ad/12913_2024_11364_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/51e443cc7a29/12913_2024_11364_Figc_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/1ebdbf7d5552/12913_2024_11364_Figd_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/13242ac7d367/12913_2024_11364_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/ab9e81ba03ad/12913_2024_11364_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/51e443cc7a29/12913_2024_11364_Figc_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/11348780/1ebdbf7d5552/12913_2024_11364_Figd_HTML.jpg

相似文献

1
Leveraging implementation science theories to develop and expand the use of a penicillin allergy de-labeling intervention.利用实施科学理论开发和扩展青霉素过敏去标签干预措施的应用。
BMC Health Serv Res. 2024 Aug 26;24(1):987. doi: 10.1186/s12913-024-11364-7.
2
Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.住院和门诊环境中青霉素过敏去标签化的障碍:一项定性研究
Allergy Asthma Clin Immunol. 2023 Oct 11;19(1):88. doi: 10.1186/s13223-023-00842-y.
3
Evaluation and Management of Penicillin Allergy.青霉素过敏的评估与管理。
Mayo Clin Proc. 2018 Jan;93(1):101-107. doi: 10.1016/j.mayocp.2017.09.020.
4
The challenge of de-labeling penicillin allergy.消除青霉素过敏标签的挑战。
Allergy. 2020 Feb;75(2):273-288. doi: 10.1111/all.13848. Epub 2019 May 26.
5
DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies.《选择性手术患者中的药物过敏标签:去青霉素标签策略中的发生率、风险和态度的前瞻性多中心横断面研究》。
Br J Anaesth. 2020 Dec;125(6):962-969. doi: 10.1016/j.bja.2020.07.048. Epub 2020 Aug 25.
6
Penicillin allergy reassessment for treatment improvement: A dental office tool to support appropriate penicillin allergy labeling.青霉素过敏再评估以改善治疗:支持适当青霉素过敏标记的牙科诊室工具。
J Am Dent Assoc. 2024 May;155(5):379-389. doi: 10.1016/j.adaj.2023.12.007. Epub 2024 Mar 21.
7
"What if the patient has a severe reaction, and it is my fault?" A qualitative study exploring factors for sustainable implementation of penicillin allergy delabelling.如果患者出现严重反应,那是我的错怎么办?一项探索青霉素过敏标签修正可持续实施因素的定性研究。
Antimicrob Resist Infect Control. 2024 Sep 2;13(1):97. doi: 10.1186/s13756-024-01456-8.
8
Barriers to paediatric penicillin allergy de-labelling in UK secondary care: a regional survey.英国二级医疗中儿童青霉素过敏重新认定的障碍:一项区域调查
Arch Dis Child. 2023 May;108(5):363-366. doi: 10.1136/archdischild-2022-324564. Epub 2022 Dec 19.
9
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches.低风险青霉素过敏脱敏:直接口服激发试验实践、实施及多学科方法的范围综述
Expert Rev Anti Infect Ther. 2024 Jan-Jun;22(1-3):59-69. doi: 10.1080/14787210.2023.2296068. Epub 2024 Feb 12.
10
Developing a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice and subsequently change antibiotic use.制定一套行为干预方案,以识别并修正英国全科医疗中不正确的青霉素过敏记录,进而改变抗生素的使用情况。
BMJ Open. 2020 Oct 1;10(10):e035793. doi: 10.1136/bmjopen-2019-035793.

本文引用的文献

1
Challenges and opportunities related to penicillin allergy in the Veterans Health Administration: a narrative review.退伍军人健康管理局中与青霉素过敏相关的挑战与机遇:一篇叙述性综述。
Antimicrob Steward Healthc Epidemiol. 2023 Oct 19;3(1):e174. doi: 10.1017/ash.2023.448. eCollection 2023.
2
Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.住院和门诊环境中青霉素过敏去标签化的障碍:一项定性研究
Allergy Asthma Clin Immunol. 2023 Oct 11;19(1):88. doi: 10.1186/s13223-023-00842-y.
3
Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.
临床决策规则在低风险青霉素过敏患者中直接口服激发试验的疗效:PALACE 随机临床试验。
JAMA Intern Med. 2023 Sep 1;183(9):944-952. doi: 10.1001/jamainternmed.2023.2986.
4
Evaluating the PEN-FAST Clinical Decision-making Tool to Enhance Penicillin Allergy Delabeling.评估PEN-FAST临床决策工具以加强青霉素过敏标签去除工作。
JAMA Intern Med. 2023 Aug 1;183(8):883-885. doi: 10.1001/jamainternmed.2023.1572.
5
Impact of a Documented Penicillin Allergy on Antibiotic Selection in Pediatric Patients With Osteomyelitis.有记录的青霉素过敏对儿童骨髓炎患者抗生素选择的影响。
Pediatr Infect Dis J. 2023 May 1;42(5):e140-e142. doi: 10.1097/INF.0000000000003863. Epub 2023 Feb 8.
6
Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice.药物过敏实践参数更新,纳入您的临床实践。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):356-368.e5. doi: 10.1016/j.jaip.2022.12.002. Epub 2022 Dec 20.
7
Penicillin allergy delabeling: Opportunities for implementation and dissemination.青霉素过敏标签去除:实施和推广的机会。
Ann Allergy Asthma Immunol. 2023 May;130(5):554-564. doi: 10.1016/j.anai.2022.12.023. Epub 2022 Dec 20.
8
Penicillin Allergy Evaluation and Health Equity: A Call to Action.青霉素过敏评估与健康公平:行动呼吁。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):422-428. doi: 10.1016/j.jaip.2022.12.001. Epub 2022 Dec 12.
9
Drug allergy: A 2022 practice parameter update.药物过敏:2022年实践参数更新
J Allergy Clin Immunol. 2022 Dec;150(6):1333-1393. doi: 10.1016/j.jaci.2022.08.028. Epub 2022 Sep 17.
10
Dental implant failure rates in patients with self-reported allergy to penicillin.自述对青霉素过敏患者的牙种植体失败率。
Clin Implant Dent Relat Res. 2022 Jun;24(3):301-306. doi: 10.1111/cid.13082. Epub 2022 Mar 21.